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Available online 17 May 2011The use of vascular closure devices (VCD) after percuta-
neous interventions has increased dramatically in the last
decade, mainly due to the shorter time to hemostasis, early
ambulation, discharge, and increased turnover with
reduced staff utilization. Although these devices add to
the cost of the procedure, have never been shown to
provide added benefit to manual compression1,2 significant
complications have been reported with their use,3e6 their
continued utilization reflects the fact that their perceived
advantages outweigh the occasional complications that are
encountered. The article by Klocker et al.7 in this issue of
EJVES reviewed all patients who required surgery for
pseudoaneurysms or local stenosis/occlusion in a very large
cohort (n Z 58,453) of patients following percutaneous
interventions between 2001e2008, and compared the
earlier time period (2001e2004) when a particular
collagen-based closure device was sparingly used to the
latter time period (2005e2008) of more liberal use of the
same device. The study has some major shortcomings: The
authors do not have specific data on the actual complica-
tion rates following VCD use or manual compression, the
sheath size, anticoagulation used, type of intervention
other anatomic parameters, and other significantDOI of original article: 10.1016/j.ejvs.2011.03.011.
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doi:10.1016/j.ejvs.2011.04.025complications which did not require surgery (i.e. major
retroperitoneal bleed, pseudoaneurysms treated success-
fully with thrombin injections or Duplex guided compres-
sion). However, the study makes some valid observations
that require attention.
The use of VCD increased 4.1-fold, from 2860 to 11,660
between the two time periods and the pseudoaneurysm
rate requiring surgery remained relatively unchanged
(0.44% vs. 0.58%), whereas the absolute number of
stenoses/occlusions increased 5.5-fold from 8 to 44, which
roughly paralleled the increase in VCD use. Even if we
assumed that all these were associated with the use of VCD,
the incidence was low; 0.28% (8 in 2860) between 2001 and
2004, and 0.37% (44 in 11,660) between 2005 and 2008,
which is similar to the rate (0.3%) found in the meta-
analysis by Biancari et al.2 It is therefore safe to say that
ischemic complications are expected to be seen at
a constant albeit a low rate following VCD use, and one has
to maintain a very high level of vigilance to identify and
prevent these infrequent (<0.5%), but potentially disas-
trous complications. This is especially difficult, but essen-
tial in high volume centers. In our hospital, all patients
have their pedal pulses checked with Doppler in addition to
manual palpation which is documented by the recovery
room nurse, and the post-procedure note includes a state-
ment by the surgeon/interventionist that the patient’s
postoperative neurovascular exam is unchanged from thatfor Vascular Surgery.
Complications after Percutaneous Interventions 237of the preoperative examination. Patients with more vague
complaints during follow up should have a complete
vascular examination with ankle-brachial indices and
Duplex imaging of the access vessels, which may reveal
significant abnormalities.8
In order to prevent access related complications, inter-
ventionists have been increasingly using either Duplex
imaging for guiding the puncture site, or at least perform an
access site angiogram following initial entry with the
micropuncture. Lastly, I would like to state my personal
bias that not all vessels can be closed with a single closure
device, and being familiar with one closure device from
each group of suture mediated, plug (collagen based or
other) or metal clip or disc base devices would allow the
interventionist to choose the best one for that particular
patient, after evaluating the artery for diameter, calcifi-
cation, and their willingness to lose wire access during
closure. Finally, manual compression should always be
considered as a safe, but labor-intensive option.References
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